The role of tumor necrosis factor-α promoter genetic variation in Takayasu arteritis susceptibility and medical treatment

Journal of Rheumatology

Volumn 38, Issue 12, 2011, Pages 2602-2607

  Lv, Naqiang ^a   Dang, Aimin ^a   Zhu, Xilin ^b   Liu, Ying ^b   Liu, Yiwen ^a   Zheng, Deyu ^a   Hui, Rutai ^a   Liu, Guozhang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Gene polymorphisms; Promoter; Takayasu arteritis; Tumor necrosis factor

Indexed keywords

ADULT; ALLELE; AORTA ARCH SYNDROME; ARTICLE; BLOOD ANALYSIS; CHINESE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TAKAYASU ARTERITIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 82755171790     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110231     Document Type: Article

References (30)

1. Andrews J, Mason JC. Takayasu's arteritis - recent advances in imaging offer promise. Rheumatology 2007;46:6-15. (Pubitemid 44932777)
2. Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet 2000;356:1023-5.
3. Inder SJ, Bobryshev YV, Cherian SM, Wang AY, Lord RS, Masuda K, et al. Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions. Cardiovasc Surg 2000;8:141-8. (Pubitemid 30110714)
4. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003;349:160-9. (Pubitemid 36818787)
5. Dhawan V, Mahajan N, Jain S. Role of C-C chemokines in Takayasu's arteritis disease. Int J Cardiol 2006;112:105-11. (Pubitemid 44247192)
6. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003;108:1469-73. (Pubitemid 37176453)
7. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 1999;100:55-60. (Pubitemid 29297940)
8. Seko Y. Takayasu arteritis: insights into immunopathology. Jpn Heart J 2000;41:15-26.
9. Numano F, Kobayashi Y. Takayasu arteritis - beyond pulselessness. Intern Med 1999;38:226-32.
10. Dang A, Wang B, Zhang Y, Zhang P, Huang J, Liu G, et al. Association of the HLA-DRB1 gene with susceptibility to aortoarteritis in a Chinese Han population. Hypertens Res 2002;25:631-4.
11. Lv N, Dang A, Wang Z, Zheng D, Liu G. Association of susceptibility to Takayasu arteritis in Chinese Han patients with HLA-DPB1. Hum Immunol 2011 May 24 (E-pub ahead of print).
12. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol 2002;55:481-6. (Pubitemid 34779296)
13. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009;10:43-55.
14. Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu's arteritis. Clin Immunol 2006;118:154-8. (Pubitemid 43199653)
15. Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology 2006;45:545-8.
16. Tripathy NK, Chauhan SK, Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 2004;138:369-74. (Pubitemid 39472458)
17. Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008;67:1567-9.
18. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004;50:2296-304. (Pubitemid 38924409)
19. Filocamo G, Buoncompagni A, Viola S, Loy A, Malattia C, Ravelli A, et al. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists. J Pediatr 2008;153:432-4.
20. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-6. (Pubitemid 28410565)
21. Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun 2004;5:315-29. (Pubitemid 39139757)
22. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34. (Pubitemid 20273298)
23. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29. (Pubitemid 24179154)
24. Ueno A, Awane Y, Wakabayashi A, Shimizu K. Successfully operated obliterative brachiocephalic arteritis (Takayasu) associated with the elongated coarctation. Jpn Heart J 1967;8:538-44.
25. Lupi E, Sanchez G, Horwitz S, Gutierrez E. Pulmonary artery involvement in Takayasu's arteritis. Chest 1975;67:69-74.
26. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation- combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009;19:519-23.
27. Dang A, Wang B, Li W, Zhang P, Liu G, Zheng D, et al. Plasma endothelin-1 levels and circulating endothelial cells in patients with aortoarteritis. Hypertens Res 2000;23:541-4.
28. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C - >A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999;8:1443-9. (Pubitemid 29374077)
29. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000;20:9113-9. (Pubitemid 32246100)
30. Freitas DS, Camargo CZ, Mariz HA, Arraes AE, de Souza AW. Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. Rheumatol Int 2010 Dec 9 (E-pub ahead of print).